Suchergebnisse - "Marzinke, Mark A"

PubPharm (262)

71

Determinants of HIV Preexposure Prophylaxis Adherence Among Female Sex Workers in a Demonstration Study in Cotonou, Benin : A Study of Behavioral and Demographic Factors

enthalten in: Sexually transmitted diseases | 2021

von Mboup, A. | Diabaté, S. | Béhanzin, L. | +9

72

Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis

enthalten in: AIDS (London, England) | 2021

von Sekabira, R. | McGowan, I. | Yuhas, K. | +17

CommentIn: AIDS. 2021 Aug 1;35(10):1691-1693. - PMID 34270492

73

Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid-organ Transplant Recipients on Continuous Veno-venous Hemodialysis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Jarrell, A. | Crow, J. | Strout, S. | +6

74

Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States

enthalten in: Journal of the International AIDS Society | 2021

von Liu, A. | Dominguez Islas, C. | Gundacker, H. | +16

75

Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis : A First-In-Human Study

enthalten in: AIDS research and human retroviruses | 2021

von Al-Khouja, A. | Shieh, E. | Fuchs, E. | +11

76

Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates

enthalten in: Advanced therapeutics | 2021

von Pons-Faudoa, F. | Sizovs, A. | Shelton, K. | +18

77

Healthcare Is a Spectrum : The Utilization of Population-Specific Reference Intervals Is Essential in the Standard of Care for Transgender Patients

enthalten in: The journal of applied laboratory medicine | 2021

von Marzinke, M. | Radix, A.

CommentOn: J Appl Lab Med. 2021 Jan 12;6(1):15-26. - PMID 32674116

78

The Journal of Applied Laboratory Medicine Special Issue on Health Disparities

enthalten in: The journal of applied laboratory medicine | 2021

von Greene, D. | Marzinke, M. | Winston-McPherson, G. | +1

79

Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates

enthalten in: Advanced Therapeutics | 2021

von Pons‐Faudoa, F. | Sizovs, A. | Shelton, K. | +18

80

Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates (Adv. Therap. 3/2021)

enthalten in: Advanced Therapeutics | 2021

von Pons‐Faudoa, F. | Sizovs, A. | Shelton, K. | +18